AIDS Research at the NIH: A Critical Review

Acknowledgments

First thanks go to Derek Link, who originally proposed this project and worked on it in its early stages.
We also thank Derek, Chris DeBlasio, and Garance Franke-Ruta for helping us with the final agonizing
edit. David Gold and Rich Lynn offered helpful suggestions and comments on work in progress. We
are grateful to Derek Hodel and the PWA Health Group for the use of their computers. At the NIH,
warmest thanks go to Linda Reck and Stan Katzman of the Office of AIDS Research, and their
colleagues, Wendy Wertheimer and Jack Whitescarver, who provided much of the source material for
this document. Each of the institutes' AIDS coordinators also deserve special mention for sending us
additional information on their programs: Judith Karp, NCI; Jim Hill and Deborah Katz, NIAID; Elaine
Sloand, NHLBI; Carl Leventhal, NINDS; Marvin Cassman, NIGMS; Joan Wilentz, NIDR; Judith Fradkin,
NIDDK; Richard Mowery, NEI; Kenneth Bridord, FIC; Janet Guthrie, NIEHS; Martha Ann Carey, NCNR;
Stanley Pillemer, NIAMS; Samuel Korper, NIA; Henry Kissman, NLM; James Snow and Pat Sparks,
NIDCD.
TAG's Mission Statement
The Treatment Action Group (TAG) fights to find a cure for AIDS and to ensure that all people living
with HIV receive the necessary treatment, care, and information they need to save their lives. TAG
focuses on the AIDS research effort, both private and public, the drug development process, and our
nation's health care delivery systems. We meet with researchers, pharmaceutical companies, and
govemrnment officials, and resort when necessary to acts of civil disobedience. We strive to develop the
scientific and political expertise needed to transform policy. TAG is committed to working for and with
all communities affected by HIV.